Evidence map›Paper›PMID 32678106›Full record

ArticleScientific data2020

Author Correction: COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms.

Marek Ostaszewski, Alexander Mazein, Marc E Gillespie, Inna Kuperstein, Anna Niarakis, Henning Hermjakob, Alexander R Pico, Egon L Willighagen, Chris T Evelo, Jan Hasenauer and 15 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific data, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Marek OstaszewskiLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.ORCID http://orcid.org/0000-0003-1473-370X
Alexander MazeinLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.ORCID http://orcid.org/0000-0001-7137-4171
Marc E GillespieOntario Institute for Cancer Research, Toronto, Canada.ORCID http://orcid.org/0000-0002-5766-1702
Inna KupersteinInstitut Curie, PSL Research University, Mines Paris Tech, Inserm, Paris, France.
Anna NiarakisDepartment of Biology, Univ. Évry, University of Paris-Saclay, Genopole, 91025, Évry, France.ORCID http://orcid.org/0000-0002-9687-7426
Henning HermjakobEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.ORCID http://orcid.org/0000-0001-8479-0262
Alexander R PicoInstitute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, United States.
Egon L WillighagenDepartment of Bioinformatics-BiGCaT, NUTRIM, Maastricht University, Maastricht, The Netherlands.ORCID http://orcid.org/0000-0001-7542-0286
Chris T EveloDepartment of Bioinformatics-BiGCaT, NUTRIM, Maastricht University, Maastricht, The Netherlands.
Jan HasenauerHelmholtz Zentrum München, Institute of Computational Biology, Neuherberg, Germany.
Falk SchreiberUniversity of Konstanz, Department of Computer and Information Science, Konstanz, Germany.
Andreas DrägerComputational Systems Biology of Infection and Antimicrobial-Resistant Pathogens, Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, 72076, Tübingen, Germany.ORCID http://orcid.org/0000-0002-1240-5553
Emek DemirDepartment of Molecular and Medical Genetics, School of Medicine, Oregon Health & Science University, Portland, USA.
Olaf WolkenhauerDepartment of Systems Biology & Bioinformatics, University of Rostock, Rostock, Germany.
Laura I FurlongResearch Programme on Biomedical informatics, Hospital del Mar Medical Research Institute, Department of experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.
Emmanuel BarillotInstitut Curie, PSL Research University, Mines Paris Tech, Inserm, Paris, France.ORCID http://orcid.org/0000-0003-2724-2002
Joaquin DopazoClinical Bioinformatics Area, Fundación Progreso y Salud. Hosp. Virgen del Rocío, Sevilla, Spain.ORCID http://orcid.org/0000-0003-3318-120X
Aurelio Orta-ResendizHIV, Inflammation and Persistence Unit, Virology Department, Institut Pasteur, Paris, France.ORCID http://orcid.org/0000-0002-6632-883X
Francesco MessinaDipartimento di Epidemiologia Ricerca Pre-Clinica e Diagnostica Avanzata, National Institute for Infectious Diseases "Lazzaro Spallanzani" i.R.c.c.S., Rome, Italy.ORCID http://orcid.org/0000-0001-8076-7217
Alfonso ValenciaBarcelona Supercomputing Center (BSC), Barcelona, Spain.
Akira FunahashiDepartment of Biosciences and Informatics, Keio University, Yokohama, Kanagawa, Japan.ORCID http://orcid.org/0000-0003-0605-239X
Hiroaki KitanoThe Systems Biology Institute, Shinagawa, Tokyo, Japan.
Charles AuffrayEuropean Institute for Systems Biology and Medicine (EISBM), Vourles, France.ORCID http://orcid.org/0000-0003-2226-7411
Rudi BallingLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
Reinhard SchneiderLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg. reinhard.schneider@uni.lu.ORCID http://orcid.org/0000-0002-8278-1618

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32678106
PMCPMC7366451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.